SYGNIS Achieves Major Milestone with the Global Launch of its first Proprietary Product: TruePrime(TM) Single Cell WGA Kit

SYGNIS AG / Key word(s): Market launch

19.01.2015 08:30

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-Hoc Announcement according to §15 WpHG

SYGNIS Achieves Major Milestone with the Global Launch of its first
Proprietary Product: TruePrime(TM) Single Cell WGA Kit

Madrid, Spain and Heidelberg, Germany, January 19th, 2015 - SYGNIS AG
(Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the
global launch of its first proprietary product for whole genome
amplification (WGA) from single cells: TruePrime(TM) Single Cell WGA Kit of
its TruePrime(TM) product line. This product launch represents a major
milestone in its recently revised corporate product and commercialization

With the TruePrime(TM) Single Cell WGA kit, SYGNIS opens up a series of
product launches based on its novel multiple displacement amplification
(MDA) technology for use with various DNA or RNA species for a multitude of
applications that provide whole genome amplification without the need of
synthetic random primers.

The TruePrime(TM) Single Cell WGA kit is in stock and will be globally
commercialized mainly through distributors as well as through SYGNIS' newly
introduced TruePrime(TM) online shop under

SYGNIS is currently developing a series of additional TruePrime(TM) kits
for a variety of applications that are expected to be launched during 2015.

-End of Ad-Hoc-

For further information please contact:

Pilar de la Huerta
Phone: +34 91 192 36 50

### Disclaimer

This publication is intended for information only and constitutes neither
an offer to sell nor an invitation to buy securities. Some statements
included in this press release, relating neither to proven financial
results nor other historical data, should be viewed as forward-looking,
i.e. not definite. Such statements are mainly predictions of future
results, trends, plans or goals. These statements should not be considered
to be total guarantees since given their very nature they are subject to
known and unknown risks and imponderability and can be affected by other
factors as a consequence of which the actual results, plans and goals of
SYGNIS AG may deviate greatly from the established conclusions or implied
predictions contained in such statements. SYGNIS does not undertake to
publicly update or revise these statements in the light of new information
or future results or for any other reason.###

19.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at and


Language: English
Company: SYGNIS AG
Im Neuenheimer Feld 515
69120 Heidelberg
Phone: 06221 454-6
Fax: 06221 454-700
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of Announcement DGAP News-Service